CRISPR Market by Offering [Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)], Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030

The global CRISPR market is anticipated to reach USD 5.47 billion by 2030 from USD 3.21 billion in 2025, at a significant CAGR of 11.2%.

The CRISPR market is experiencing substantial growth, with a notable CAGR driven by its increasing adoption in research, clinical, and industrial applications. Several factors contribute to this market expansion, including the rising prevalence of genetic disorders, the growing use of CRISPR in drug discovery and gene therapy, and increased investments in biotechnology research and development. Additionally, advancements in CRISPR tools, improved delivery systems, and supportive regulatory developments further accelerate its integration into mainstream research and therapeutic pipelines.

“Products dominated the CRISPR market, by offering, in 2024.”

Based on offerings, the CRISPR market is categorized into two main segments: products and services. The products segment includes CRISPR kits & enzymes, CRISPR libraries, and other products. The services segment encompasses gRNA synthesis & cell line development, screening & validation, and other services.

Users are increasingly seeking ongoing innovations, new product releases, and access to standardized, ready-to-use kits. These products are widely utilized in academic, clinical, and industrial research for applications in genome editing, functional genomics, and therapeutic development. This is a key factor driving market growth.

“The drug discovery & development application segment is anticipated to grow at a faster pace during the forecast period.”

The application segment is divided into three categories: drug discovery & development, agriculture, and other applications. The largest segment is drug discovery & development, as CRISPR technology enhances early-stage research by facilitating the identification of connections between genes and diseases, as well as drug functions. This approach helps reduce timelines and increase the likelihood of success. Additionally, pharmaceutical & biotechnology companies are integrating CRISPR into their research and development processes to advance personalized medicine, gene therapy, and functional genomics, thereby enhancing the utilization of CRISPR technology.

“Pharmaceutical & biotechnology companies dominated the CRISPR products market, by end user, in 2024.”

Based on end users, the CRISPR products market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and other end users. In 2024, pharmaceutical & biotechnology companies dominated this market. This dominance is driven by increasing investments in cell and gene therapies, as well as the demand for precise genetic tools for target identification and validation. These companies rely heavily on CRISPR technologies, and their strong financial capacity allows them to adopt advanced and customized CRISPR products at scale, further contributing to their significant market share.

“North America accounted for the largest share of the CRISPR market in 2024.”

The market is divided by region into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest share of the CRISPR market and is expected to maintain its lead. This dominance is attributed to the presence of prominent research institutions and significant investments in biotechnology. Additionally, the growing emphasis on cutting-edge medical research, personalized medicine, and precision medicine in the US gives North America a competitive advantage. The European CRISPR market is also experiencing steady growth, fueled by increased research and development efforts, particularly in countries such as Germany, the UK, and France.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the CRISPR market.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side (70%) and Demand Side (30%)
• By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
• By Region: North America (35%), Europe (30%), Asia Pacific (25%), Latin America (5%), and the Middle East & Africa (5%)

The prominent players operating in the CRISPR market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), GenScript (US), Takara Bio (Japan), Creative Biogene (US), Fujian SunyBiotech Co., Ltd. (China), EditCo (US), Caribou Biosciences, Inc. (US), Lonza Group (Switzerland), Danaher Corporation (US), Revvity, Inc. (US), Hera BioLabs (US), OriGene Technologies, Inc. (US), Cellecta, Inc. (US), Mammoth Biosciences, Inc. (US), Applied StemCell (US), New England Biolabs Inc. (US), ToolGen Inc. (South Korea), GeneCopoeia, Inc. (US), Twist Bioscience Corporation (US), Synthego Corporation (US), eGenesis (US), Inscripta, Inc. (US), and Precision BioSciences, Inc. (US), among others.

Research Coverage:

The CRISPR market report is segmented based on offerings [products (CRISPR kits & enzymes, CRISPR libraries, and other products), services (gRNA synthesis & cell line development, screening & validation, and other services)], applications (drug discovery & development, agriculture, and other applications), and end users [product (pharmaceutical & biotechnology companies, academic & research institutes, and other end users), and service (pharmaceutical & biotechnology companies, academic & research institutes, and other end users)].

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the CRISPR market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. The report also covers new launches, collaborations, acquisitions, and recent developments associated with the CRISPR market.

Key Benefits of Buying the Report:

The report will assist both market leaders and new entrants by providing accurate revenue estimates for CRISPR and its subsegments. It will also help stakeholders better understand the competitive landscape, enabling them to position their businesses effectively and develop suitable go-to-market strategies. Additionally, this report will allow stakeholders to gauge the market dynamics and offer insights into the key drivers, restraints, opportunities, and challenges within the market.

The report provides insights into the following pointers:

• Analysis of key drivers (growing demand for CRISPR-based gene therapies, advancements in CRISPR technology, and growing government and private investments and funding for CRISPR technology), restraints (technical challenges associated with CRISPR technology), opportunities (development of new vaccines and treatments for genetic diseases and expanding industrial and agricultural applications of CRISPR), and challenges (regulatory hurdles for CRISPR advancements) influencing the growth of the market.
• Product Development/Innovation: In-depth analysis of emerging technologies in CRISPR, R&D activities, and new product launches in the CRISPR market.
• Market Development: The report provides detailed information about profitable markets and analyzes the market conditions across various regions.
• Market Diversification: Comprehensive information about new products, unexplored regions, recent updates, and investments in the CRISPR market.
• Competitive Assessment: Comprehensive evaluation of market shares, growth strategies, and product & service offerings of leading companies such as Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), and GenScript (US).

Tables List

Table 1 Impact Analysis Of Supply-side And Demand-side Factors

Table 2 Crispr Market: Risk Analysis

Table 3 Crispr Market: Impact Analysis

Table 4 Crispr Market: Role Of Companies In Ecosystem

Table 5 Crispr Market: Porter’s Five Forces Analysis

Table 6 North America: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 7 Europe: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 8 Asia Pacific: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 9 Latin America: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 10 Middle East & Africa: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 11 Average Selling Price Trend Of Crispr Kits & Reagents,

By Key Player, 2022–2024

Table 12 Average Selling Price Trend Of Crispr Kits And Reagents,

By Region, 2024 (Usd)

Table 13 Crispr Market: Innovations And Patent Registrations

Table 14 Crispr Market: Key Conferences & Events, 2025–2026

Table 15 Crispr Market: Influence Of Stakeholders On Buying Process (%)

Table 16 Import Data For Kits & Reagents, By Region, 2019–2023 (Usd)

Table 17 Export Data For Kits & Reagents, By Region, 2019–2023 (Usd)

Table 18 Us-adjusted Reciprocal Tariff Rates

Table 19 Key Tariffs On Pharmaceutical Products

Table 20 Critical Components Likely Exposed To Tariff Changes

Table 21 Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 22 Crispr Products Market, By Region, 2023–2030 (Usd Million)

Table 23 North America: Crispr Products Market, By Country,

2023–2030 (Usd Million)

Table 24 Europe: Crispr Products Market, By Country, 2023–2030 (Usd Million)

Table 25 Asia Pacific: Crispr Products Market, By Country,

2023–2030 (Usd Million)

Table 26 Latin America: Crispr Products Market, By Country,

2023–2030 (Usd Million)

Table 27 Crispr Services Market, By Region, 2023–2030 (Usd Million)

Table 28 North America: Crispr Services Market, By Country,

2023–2030 (Usd Million)

Table 29 Europe: Crispr Services Market, By Country, 2023–2030 (Usd Million)

Table 30 Asia Pacific: Crispr Services Market, By Country,

2023–2030 (Usd Million)

Table 31 Latin America: Crispr Services Market, By Country,

2023–2030 (Usd Million)

Table 32 Crispr Products Market, By Type, 2023–2030 (Usd Million)

Table 33 Crispr Kits & Enzymes Market, By Region, 2023–2030 (Usd Million)

Table 34 North America: Crispr Kits & Enzymes Market, By Country,

2023–2030 (Usd Million)

Table 35 Europe: Crispr Kits & Enzymes Market, By Country,

2023–2030 (Usd Million)

Table 36 Asia Pacific: Crispr Kits & Enzymes Market, By Country,

2023–2030 (Usd Million)

Table 37 Latin America: Crispr Kits & Enzymes Market, By Country,

2023–2030 (Usd Million)

Table 38 Crispr Libraries Market, By Region, 2023–2030 (Usd Million)

Table 39 North America: Crispr Libraries Market, By Country,

2023–2030 (Usd Million)

Table 40 Europe: Crispr Libraries Market, By Country, 2023–2030 (Usd Million)

Table 41 Asia Pacific: Crispr Libraries Market, By Country,

2023–2030 (Usd Million)

Table 42 Latin America: Crispr Libraries Market, By Country,

2023–2030 (Usd Million)

Table 43 Other Crispr Products Market, By Region, 2023–2030 (Usd Million)

Table 44 North America: Other Crispr Products Market, By Country,

2023–2030 (Usd Million)

Table 45 Europe: Other Crispr Products Market, By Country,

2023–2030 (Usd Million)

Table 46 Asia Pacific: Other Crispr Products Market, By Country,

2023–2030 (Usd Million)

Table 47 Latin America: Other Crispr Products Market, By Country,

2023–2030 (Usd Million)

Table 48 Crispr Products Market, By End User, 2023–2030 (Usd Million)

Table 49 Crispr Products Market For Pharmaceutical & Biotechnology Companies, By Region, 2023–2030 (Usd Million)

Table 50 North America: Crispr Products Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)

Table 51 Europe: Crispr Products Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)

Table 52 Asia Pacific: Crispr Products Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)

Table 53 Latin America: Crispr Products Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)

Table 54 Crispr Products Market For Academic & Research Institutes,

By Region, 2023–2030 (Usd Million)

Table 55 North America: Crispr Products Market For Academic & Research Institutes, By Country, 2023–2030 (Usd Million)

Table 56 Europe: Crispr Products Market For Academic & Research Institutes, By Country, 2023–2030 (Usd Million)

Table 57 Asia Pacific: Crispr Products Market For Academic & Research Institutes, By Country, 2023–2030 (Usd Million)

Table 58 Latin America: Crispr Products Market For Academic & Research Institutes, By Country, 2023–2030 (Usd Million)

Table 59 Crispr Products Market For Other End Users, By Region,

2023–2030 (Usd Million)

Table 60 North America: Crispr Products Market For Other End Users,

By Country, 2023–2030 (Usd Million)

Table 61 Europe: Crispr Products Market For Other End Users, By Country, 2023–2030 (Usd Million)

Table 62 Asia Pacific: Crispr Products Market For Other End Users,

By Country, 2023–2030 (Usd Million)

Table 63 Latin America: Crispr Products Market For Other End Users,

By Country, 2023–2030 (Usd Million)

Table 64 Crispr Market, By Service, 2023–2030 (Usd Million)

Table 65 Crispr Services Market For Grna Synthesis & Cell Line Development, By Region, 2023–2030 (Usd Million)

Table 66 North America: Crispr Services Market For Grna Synthesis & Cell Line Development, By Country, 2023–2030 (Usd Million)

Table 67 Europe: Crispr Services Market For Grna Synthesis & Cell Line Development, By Country, 2023–2030 (Usd Million)

Table 68 Asia Pacific: Crispr Services Market For Grna Synthesis & Cell Line Development, By Country, 2023–2030 (Usd Million)

Table 69 Latin America: Crispr Services Market For Grna Synthesis &

Cell Line Development, By Country, 2023–2030 (Usd Million)

Table 70 Crispr Services Market For Screening & Validation, By Region,

2023–2030 (Usd Million)

Table 71 North America: Crispr Services Market For Screening & Validation,

By Country, 2023–2030 (Usd Million)

Table 72 Europe: Crispr Services Market For Screening & Validation,

By Country, 2023–2030 (Usd Million)

Table 73 Asia Pacific: Crispr Services Market For Screening & Validation,

By Country, 2023–2030 (Usd Million)

Table 74 Latin America: Crispr Services Market For Screening & Validation,

By Country, 2023–2030 (Usd Million)

Table 75 Other Crispr Services Market, By Region, 2023–2030 (Usd Million)

Table 76 North America: Other Crispr Services Market, By Country,

2023–2030 (Usd Million)

Table 77 Europe: Other Crispr Services Market, By Country,

2023–2030 (Usd Million)

Table 78 Asia Pacific: Other Crispr Services Market, By Country,

2023–2030 (Usd Million)

Table 79 Latin America: Other Crispr Services Market, By Country,

2023–2030 (Usd Million)

Table 80 Crispr Services Market, By End User, 2023–2030 (Usd Million)

Table 81 Crispr Services Market For Pharmaceutical & Biotechnology Companies, By Region, 2023–2030 (Usd Million)

Table 82 North America: Crispr Services Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)

Table 83 Europe: Crispr Services Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)

Table 84 Asia Pacific: Crispr Services Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)

Table 85 Latin America: Crispr Services Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)

Table 86 Crispr Services Market For Academic & Research Institutes,

By Region, 2023–2030 (Usd Million)

Table 87 North America: Crispr Services Market For Academic & Research Institutes, By Country, 2023–2030 (Usd Million)

Table 88 Europe: Crispr Services Market For Academic & Research Institutes,

By Country, 2023–2030 (Usd Million)

Table 89 Asia Pacific: Crispr Services Market For Academic & Research Institutes, By Country, 2023–2030 (Usd Million)

Table 90 Latin America: Crispr Services Market For Academic & Research Institutes, By Country, 2023–2030 (Usd Million)

Table 91 Crispr Services Market For Other End Users, By Region,

2023–2030 (Usd Million)

Table 92 North America: Crispr Services Market For Other End Users,

By Country, 2023–2030 (Usd Million)

Table 93 Europe: Crispr Services Market For Other End Users, By Country, 2023–2030 (Usd Million)

Table 94 Asia Pacific: Crispr Services Market For Other End Users,

By Country, 2023–2030 (Usd Million)

Table 95 Latin America: Crispr Services Market For Other End Users,

By Country, 2023–2030 (Usd Million)

Table 96 Crispr Market, By Application, 2023–2030 (Usd Million)

Table 97 Crispr Market For Drug Discovery & Development Applications,

By Region, 2023–2030 (Usd Million)

Table 98 North America: Crispr Market For Drug Discovery & Development Applications, By Country, 2023–2030 (Usd Million)

Table 99 Europe: Crispr Market For Drug Discovery & Development Applications, By Country, 2023–2030 (Usd Million)

Table 100 Asia Pacific: Crispr Market For Drug Discovery & Development Applications, By Country, 2023–2030 (Usd Million)

Table 101 Latin America: Crispr Market For Drug Discovery & Development Applications, By Country, 2023–2030 (Usd Million)

Table 102 Crispr Market For Agricultural Applications, By Region,

2023–2030 (Usd Million)

Table 103 North America: Crispr Market For Agricultural Applications,

By Country, 2023–2030 (Usd Million)

Table 104 Europe: Crispr Market For Agricultural Applications, By Country, 2023–2030 (Usd Million)

Table 105 Asia Pacific: Crispr Market For Agricultural Applications, By Country, 2023–2030 (Usd Million)

Table 106 Latin America: Crispr Market For Agricultural Applications,

By Country, 2023–2030 (Usd Million)

Table 107 Crispr Market For Other Applications, By Region,

2023–2030 (Usd Million)

Table 108 North America: Crispr Market For Other Applications, By Country, 2023–2030 (Usd Million)

Table 109 Europe: Crispr Market For Other Applications, By Country,

2023–2030 (Usd Million)

Table 110 Asia Pacific: Crispr Market For Other Applications, By Country,

2023–2030 (Usd Million)

Table 111 Latin America: Crispr Market For Other Applications, By Country,

2023–2030 (Usd Million)

Table 112 Crispr Market, By Region, 2023–2030 (Usd Million)

Table 113 North America: Key Macroindicators

Table 114 North America: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 115 North America: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 116 North America: Crispr Products Market, By End User,

2023–2030 (Usd Million)

Table 117 North America: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 118 North America: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 119 North America: Crispr Services Market, By End User,

2023–2030 (Usd Million)

Table 120 Us: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 121 Us: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 122 Us: Crispr Products Market, By End User, 2023–2030 (Usd Million)

Table 123 Us: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 124 Us: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 125 Us: Crispr Services Market, By End User, 2023–2030 (Usd Million)

Table 126 Canada: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 127 Canada: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 128 Canada: Crispr Products Market, By End User, 2023–2030 (Usd Million)

Table 129 Canada: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 130 Canada: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 131 Canada: Crispr Services Market, By End User, 2023–2030 (Usd Million)

Table 132 Europe: Key Macroindicators

Table 133 Europe: Crispr Market, By Country, 2023–2030 (Usd Million)

Table 134 Europe: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 135 Europe: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 136 Europe: Crispr Products Market, By End User, 2023–2030 (Usd Million)

Table 137 Europe: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 138 Europe: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 139 Europe: Crispr Services Market, By End User, 2023–2030 (Usd Million)

Table 140 Germany: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 141 Germany: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 142 Germany: Crispr Products Market, By End User,

2023–2030 (Usd Million)

Table 143 Germany: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 144 Germany: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 145 Germany: Crispr Services Market, By End User, 2023–2030 (Usd Million)

Table 146 Uk: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 147 Uk: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 148 Uk: Crispr Products Market, By End User, 2023–2030 (Usd Million)

Table 149 Uk: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 150 Uk: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 151 Uk: Crispr Services Market, By End User, 2023–2030 (Usd Million)

Table 152 France: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 153 France: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 154 France: Crispr Products Market, By End User, 2023–2030 (Usd Million)

Table 155 France: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 156 France: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 157 France: Crispr Services Market, By End User, 2023–2030 (Usd Million)

Table 158 Italy: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 159 Italy: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 160 Italy: Crispr Products Market, By End User, 2023–2030 (Usd Million)

Table 161 Italy: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 162 Italy: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 163 Italy: Crispr Services Market, By End User, 2023–2030 (Usd Million)

Table 164 Spain: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 165 Spain: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 166 Spain: Crispr Products Market, By End User, 2023–2030 (Usd Million)

Table 167 Spain: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 168 Spain: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 169 Spain: Crispr Services Market, By End User, 2023–2030 (Usd Million)

Table 170 Rest Of Europe: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 171 Rest Of Europe: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 172 Rest Of Europe: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 173 Rest Of Europe: Crispr Products Market, By End User,

2023–2030 (Usd Million)

Table 174 Rest Of Europe: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 175 Rest Of Europe: Crispr Services Market, By End User,

2023–2030 (Usd Million)

Table 176 Asia Pacific: Key Macro Indicators

Table 177 Asia Pacific: Crispr Market, By Country, 2023–2030 (Usd Million)

Table 178 Asia Pacific: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 179 Asia Pacific: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 180 Asia Pacific: Crispr Products Market, By End User,

2023–2030 (Usd Million)

Table 181 Asia Pacific: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 182 Asia Pacific: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 183 Asia Pacific: Crispr Services Market, By End User,

2023–2030 (Usd Million)

Table 184 China: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 185 China: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 186 China: Crispr Products Market, By End User, 2023–2030 (Usd Million)

Table 187 China: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 188 China: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 189 China: Crispr Services Market, By End User, 2023–2030 (Usd Million)

Table 190 Japan: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 191 Japan: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 192 Japan: Crispr Products Market, By End User, 2023–2030 (Usd Million)

Table 193 Japan: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 194 Japan: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 195 Japan: Crispr Services Market, By End User, 2023–2030 (Usd Million)

Table 196 India: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 197 India: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 198 India: Crispr Products Market, By End User, 2023–2030 (Usd Million)

Table 199 India: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 200 India: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 201 India: Crispr Services Market, By End User, 2023–2030 (Usd Million)

Table 202 Rest Of Asia Pacific: Crispr Market, By Offering,

2023–2030 (Usd Million)

Table 203 Rest Of Asia Pacific: Crispr Market, By Product,

2023–2030 (Usd Million)

Table 204 Rest Of Asia Pacific: Crispr Products Market, By End User,

2023–2030 (Usd Million)

Table 205 Rest Of Asia Pacific: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 206 Rest Of Asia Pacific: Crispr Market, By Application,

2023–2030 (Usd Million)

Table 207 Rest Of Asia Pacific: Crispr Services Market, By End User,

2023–2030 (Usd Million)

Table 208 Latin America: Key Macroindicators

Table 209 Latin America: Crispr Market, By Country, 2023–2030 (Usd Million)

Table 210 Latin America: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 211 Latin America: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 212 Latin America: Crispr Products Market, By End User,

2023–2030 (Usd Million)

Table 213 Latin America: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 214 Latin America: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 215 Latin America: Crispr Services Market, By End User,

2023–2030 (Usd Million)

Table 216 Brazil: Crispr Market, By Offering, 2023–2030 (Usd Million)

Table 217 Brazil: Crispr Market, By Product, 2023–2030 (Usd Million)

Table 218 Brazil: Crispr Products Market, By End User, 2023–2030 (Usd Million)

Table 219 Brazil: Crispr Market, By Service, 2023–2030 (Usd Million)

Table 220 Brazil: Crispr Market, By Application, 2023–2030 (Usd Million)

Table 221 Brazil: Crispr Services Market, By End User, 2023–2030 (Usd Million)

Table 222 Rest Of Latin America: Crispr Market, By Offering,

2023–2030 (Usd Million)

Table 223 Rest Of Latin America: Crispr Market, By Product,

2023–2030 (Usd Million)

Table 224 Rest Of Latin America: Crispr Products Market, By End User,

2023–2030 (Usd Million)

Table 225 Rest Of Latin America: Crispr Market, By Service,

2023–2030 (Usd Million)

Table 226 Rest Of Latin America: Crispr Market, By Application,

2023–2030 (Usd Million)

Table 227 Rest Of Latin America: Crispr Services Market, By End User,

2023–2030 (Usd Million)

Table 228 Middle East & Africa: Key Macroindicators

Table 229 Middle East & Africa: Crispr Market, By Offering,

2023–2030 (Usd Million)

Table 230 Middle East & Africa: Crispr Market, By Product,

2023–2030 (Usd Million)

Table 231 Middle East & Africa: Crispr Products Market, By End User,

2023–2030 (Usd Million)

Table 232 Middle East & Africa: Crispr Market, By Service,

2023–2030 (Usd Million)

Table 233 Middle East & Africa: Crispr Market, By Application,

2023–2030 (Usd Million)

Table 234 Middle East & Africa: Crispr Services Market, By End User,

2023–2030 (Usd Million)

Table 235 Strategies Adopted By Key Players In Crispr Market, 2021−2025

Table 236 Crispr Market: Degree Of Competition

Table 237 Crispr Market: Region Footprint

Table 238 Crispr Market: Product Footprint

Table 239 Crispr Market: Service Footprint

Table 240 Crispr Market: Application Footprint

Table 241 Crispr Market: Detailed List Of Key Startups/Smes

Table 242 Crispr Market: Competitive Benchmarking Of Key Start Ups/Smes

Table 243 Crispr Market: Product Launches, January 2021–march 2025

Table 244 Crispr Market: Deals, January 2021–march 2025

Table 245 Crispr Market: Expansions, January 2021–march 2025

Table 246 Thermo Fisher Scientific Inc.: Company Overview

Table 247 Thermo Fisher Scientific Inc.: Products/Services Offered

Table 248 Thermo Fisher Scientific Inc.: Product/Service Launches,

January 2021–january 2025

Table 249 Thermo Fisher Scientific Inc.: Deals, January 2021–january 2025

Table 250 Thermo Fisher Scientific Inc.: Expansions, January 2021–january 2025

Table 251 Merck Kgaa: Company Overview

Table 252 Merck Kgaa: Products/Services Offered

Table 253 Merck Kgaa: Deals, January 2021–january 2025

Table 254 Agilent Technologies, Inc.: Company Overview

Table 255 Agilent Technologies, Inc.: Products/Services Offered

Table 256 Agilent Technologies, Inc.: Deals, January 2021–march 2025

Table 257 Agilent Technologies, Inc.: Expansions, January 2021–march 2025

Table 258 Genscript: Company Overview

Table 259 Genscript: Products/Services Offered

Table 260 Genscript: Product/Service Approvals/Launches,

January 2021–march 2025

Table 261 Genscript: Deals, January 2021–march 2025

Table 262 Genscript: Expansions, January 2021–march 2025

Table 263 Revvity: Company Overview

Table 264 Revvity: Products/Services Offered

Table 265 Revvity: Deals, January 2021–march 2025

Table 266 Lonza: Company Overview

Table 267 Lonza: Products/Services Offered

Table 268 Lonza: Deals, January 2021–march 2025

Table 269 Danaher Corporation: Company Overview

Table 270 Danaher Corporation: Products/Services Offered

Table 271 Danaher Corporation: Deals, January 2021–march 2025

Table 272 Takara Bio Inc.: Company Overview

Table 273 Takara Bio Inc.: Products/Services Offered

Table 274 Takara Bio Inc.: Deals, January 2021–march 2025

Table 275 Creative Biogene: Company Overview

Table 276 Creative Biogene: Products/Services Offered

Table 277 Creative Biogene: Product/Service Approvals/Launches,

January 2021–march 2025

Table 278 Fujian Sunybiotech Co., Ltd.: Company Overview

Table 279 Fujian Sunybiotech Co., Ltd.: Products/Services Offered

Table 280 Editco: Company Overview

Table 281 Editco: Products/Services Offered

Table 282 Editco: Deals, January 2021–march 2025

Table 283 Caribou Biosciences, Inc.: Company Overview

Table 284 Caribou Biosciences, Inc.: Products/Services Offered

Table 285 Caribou Biosciences, Inc.: Deals, January 2021–march 2025

Table 286 Hera Biolabs: Company Overview

Table 287 Hera Biolabs: Products/Services Offered

Table 288 Origene Technologies, Inc.: Company Overview

Table 289 Origene Technologies, Inc.: Products/Services Offered

Table 290 Cellecta, Inc.: Company Overview

Table 291 Cellecta, Inc.: Products/Services Offered

Table 292 Mammoth Biosciences, Inc.: Company Overview

Table 293 Applied Stemcell: Company Overview

Table 294 New England Biolabs: Company Overview

Table 295 Toolgen, Inc.: Company Overview

Table 296 Genecopoeia, Inc.: Company Overview

Table 297 Twist Bioscience: Company Overview

Table 298 Synthego: Company Overview

Table 299 Egenesis: Company Overview

Table 300 Inscripta, Inc.: Company Overview

Table 301 Precision Biosciences: Company Overview

Figures List

Figure 1 Crispr Market Segmentation & Regional Scope

Figure 2 Crispr Market: Research Design

Figure 3 Crispr Market: Breakdown Of Primary Interviews

Figure 4 Crispr Market Size Estimation (Supply-side Analysis), 2024

Figure 5 Crispr Market Estimation: Approach 1 (Company Revenue Analysis-based Estimation), 2024

Figure 6 Illustrative Example Of Thermo Fisher Scientific Inc.:

Revenue Share Analysis (2024)

Figure 7 Market Size Validation From Primary Sources

Figure 8 Segmental Market Size Estimation Methodology: Top-down Approach

Figure 9 Crispr Market: Cagr Projections

Figure 10 Data Triangulation Methodology

Figure 11 Crispr Market, By Offering, 2025 Vs. 2030 (Usd Million)

Figure 12 Crispr Market, By Application, 2025 Vs. 2030 (Usd Million)

Figure 13 Crispr Market: Geographical Snapshot

Figure 14 Rising Focus On Crispr Therapeutics Development To Drive Growth

Figure 15 Drug Discovery & Development Segment To Account For Largest Market Share In 2024

Figure 16 Pharmaceutical & Biotechnology Companies To Account For Largest Market Share During Forecast Period

Figure 17 Crispr Market: Drivers, Restraints, Opportunities, And Challenges

Figure 18 Top 10 Leading Crispr Startups Based On Investments Raised In 2024

Figure 19 Crispr Market: Trends/Disruptions Impacting Customers’ Businesses

Figure 20 Crispr Market: Supply Chain Analysis

Figure 21 Crispr Market: Value Chain Analysis

Figure 22 Crispr Market: Ecosystem Analysis

Figure 23 Crispr Market: Porter’s Five Forces Analysis

Figure 24 Average Selling Price Of Kits And Reagents, By Key Player (2024)

Figure 25 Average Selling Price Of Kits & Reagents, By Region, 2024 (Usd)

Figure 26 Patent Applications For Crispr (January 2014–december 2024)

Figure 27 Crispr Market: Influence Of Stakeholders On Buying Process

Figure 28 Key Buying Criteria Of End Users For Crispr Products

Figure 29 Key Selection Criteria Of End Users For Crispr Services

Figure 30 Crispr Market: Investment & Funding Scenario

Figure 31 Impact Of Ai/Gen Ai On Crispr Market

Figure 32 North America: Crispr Market Snapshot

Figure 33 Asia Pacific: Crispr Market Snapshot

Figure 34 Revenue Analysis Of Key Players In Crispr Market, 2020−2024

Figure 35 Market Share Analysis Of Key Players In Crispr Market, 2024

Figure 36 Crispr Market: Company Evaluation Matrix (Key Players), 2024

Figure 37 Crispr Market: Company Footprint

Figure 38 Crispr Market: Company Evaluation Matrix (Startups/Smes), 2024

Figure 39 Year-to-date (Ytd) Price Total Return And 5-year Stock Beta

Of Key Vendors, 2024

Figure 40 Ev/Ebitda Of Key Players, 2024

Figure 41 Crispr Market: Brand/Product Comparison

Figure 42 Thermo Fisher Scientific Inc.: Company Snapshot (2024)

Figure 43 Merck Kgaa: Company Snapshot (2024)

Figure 44 Agilent Technologies, Inc.: Company Snapshot (2024)

Figure 45 Genscript: Company Snapshot (2023)

Figure 46 Revvity: Company Snapshot (2024)

Figure 47 Lonza: Company Snapshot (2024)

Figure 48 Danaher Corporation: Company Snapshot (2024)

Figure 49 Takara Bio Inc.: Company Snapshot (2023)

Figure 50 Caribou Biosciences, Inc.: Company Snapshot (2024)